期刊文献+

骨唾液酸蛋白-β-磷酸三钙人工骨的研制及释放实验 被引量:4

Preparation and protein release of bone sialoprotein-beta-tricalcium phosphate artificial bone
在线阅读 下载PDF
导出
摘要 目的:研制骨唾液酸蛋白-β-磷酸三钙(BSP-β-TCP)人工骨并观察BSP-β-TCP中骨唾液酸蛋白的释放规律。方法:实验于2006-12/2007-07在解放军广州军区广州总医院医学实验科完成。①BSP-β-TCP人工骨制备:采用低温负压冻干的方法将骨唾液酸蛋白复合于β-磷酸三钙中,按骨唾液酸蛋白含量不同制备两种样品:A样品含骨唾液酸蛋白1﹪,B样品含骨唾液酸蛋白2﹪。②观察指标:两种样品分别在恒温空气浴振荡器内(37±1)℃持续振荡。试验开始2周内每24h,以后每72h时分别吸出浸泡液100μL/次,共观察4周。用考马斯亮蓝法测定各个时间点溶液中蛋白质含量;绘制出蛋白质释放量和时间关系的散点图,再将散点图的曲线直线化,分析BSP-β-TCP人工骨中骨唾液酸蛋白的释放动力学。结果:①骨唾液酸蛋白释放率:72h内有一个爆发性的释放,释放率A样品为25.44﹪,B样品为35.11﹪;10d内的释放速度较快,A样品为39.76﹪,B样品为44.13﹪;持续4周仍有缓慢释放,A样品为55.43﹪,B样品为56.82﹪。②骨唾液酸蛋白的释放动力学:将散点图曲线进行拟和后可见释放量与时间(h)平方根成线性关系,两者的关系符合Higuchi方程。结论:骨唾液酸蛋白以扩散方式释放,β-磷酸三钙可作为良好的载体与BSP共同形成缓释系统。 AIM: To prepare bone sialoprotein- β -tricalcium phosphate (BSP- β -TCP) artificial bone and observe releasing rule of BSP in the artificial bone. METHODS: The experiment was carried out in the Medical Laboratory of Guangzhou General Hospital of Guangzhou Military Area Command of Chinese PLA between December 2006 and July 2007.(1)BSP in combination with β -TCP was conducted by using low temperature, negative pressure and freeze-dried device, to prepare BSP- β -TCP artificial bone. Two kinds of BSP- β -TCP artificial bone were produced according to the content of BSP: A sample (containing 1% BSP) and B sample (containing 2% BSP). (2)The two samples were persis0. tently oscillated in constant temperatm-e air bath (37± 1)℃. The soak was inhausted 100μ L per time every 24 hours within two weeks after experiment, and then every 72 hours later, the observation lasted 4 weeks. Coomassie brilliant blue method was used to determine the protein content in solution at every time point. The scatterplot of relation between protein releasing amount and time was drawn, then lined curve of scatterplot was conducted to analyze releasing kinetics of BSP in BSP- β -TCP artificial bone. RESULTS: (1)BSP had an breaking out delivery in 72 hours, and the BSP release rate of A sample was 25.44% while that of B sample was 35.11%; BSP kept a high releasing rate in 10 days, 39.76% in A sample and 44.13% in B sample; slow releasing still remained for 4 weeks, the BSP release rate of A sample was 55.43%, and that of B sample was 56.82%.(2)After making the curve fitting of scatterplot, the linear correlation relationship between the release amount of BSP and the square root of time (hour) was found, in agreement with Higuchi equation. CONCLUSION: BSP release from BSP- β -TCP artificial bone in a diffuse manner. As a carrier, β -TCP can form slow-release system with BSP.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2008年第1期27-30,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 2005广东省科技三项经费计划项目(2005B34001008)~~
作者简介 王玮,男,1982年生,江西省德兴市人,汉族,2007年广州医学院毕业,硕士,医师,主要从事骨组织工程研究。myemai1306@tom.com. 通讯作者:章莹,博士,副主任医师,解放军广州军区广州总医院骨科,广东省广州市510010zhangying—doc@yahoo.com.cn
  • 相关文献

参考文献20

  • 1Fisher LW, Whitson SW, Avioli LV, et al. Matrix sialoprotein of developing bone. J Biol Chem 1983:258(20):12723-12727
  • 2Oldberg A, Franzen A, Heinegard D, et al.Identification of a bone sialoprotein receptor in osteosarcoma cells. J Biol Chem 1988;263(36):19433-19436
  • 3Hultenby K, Reinholt FP, Norgard M, et al. Distribution and synthesis of bone sialoprotein in metaphyseal bone of young rats show a distinctly different pattern from that of osteopontin. Eur J Cell Biol 1994;63(2):230-239
  • 4Kishimoto M, Kanemaru S, Yamashita M, et al. Cranial boneregeneration using a composite scaffold of Beta-tricalcium phosphate,collagen,and autologous bone fragments. Laryngoscope 2006;116(2):212-216
  • 5Zou C, Weng W, Deng X, et al.Preparation and characterization of porous beta-tricalcium phosphate/collagen composites with an integrated structure.Biomaterials 2005;26 (26):5276-5284
  • 6Fujita R, Yokoyama A, Nodasaka Y, et al . Ultrastructure of ceramic-bone interface using hydroxyapatite and beta-tricalcium phosphate ceramics and replacement mechanism of beta-tricalcium phosphate in bone.Tissue Cell 2003;35(6):427-440
  • 7Eppley BL, Pietrzak WS, Blanton MW. Allograft and alloplastic bone substitutes: a review of science and technology for the craniomaxillofacial surgeon. J Craniofac Surg 2005;16(6):981-989
  • 8Artzi Z, Weinreb M, Givol N, et al. Biomaterial resorption rate and healing site morphology of inorganic bovine bone and beta-tricalcium phosphate in the canine: a 24-month longitudinal histologic study and morphometric analysis. Int J Oral Maxillofac Implants 2004;19(3):357-368
  • 9王金熙,吴士良,周海斌,郑祖根.纯化天然骨唾液蛋白的体内成骨活性[J].中华骨科杂志,2000,20(4):234-238. 被引量:7
  • 10O'Toole GC, Salih E, Gallagher C,et al. Bone sialoprotein-coated femoral implants are osteoinductive but mechanically compromised. J Orthop Res 2004;22(3):641-646

二级参考文献25

  • 1[7]Trimble R B, Atkinson P H, Tschopp J F, Townsend R R, Maley F.Structure of oligosaccharides on Saccharomyces SUC2 invertase secreted by the methylotrophic yeast Pichia pastoris. J Biol Chem, 1991, 266(34): 22807 ~ 22817
  • 2[8]Andersen D C, Goochee C F. The effect of cell-culture conditions on the oligosaccharide structures of secreted glycoproteins. Curr Opin Biotechnol, 1994, 5(5): 546 ~ 549
  • 3[2]Fisher L W, Torchia D A, Fohr B, Young M F, Fedarko N S. Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin.Biochem Biophys Res Commun, 2001, 280(2): 460 ~ 465
  • 4[3]Stubbs J T 3rd, Mintz K P, Eanes E D, Torchia D A, Fisher L W.Characterization of native and recombinant bone sialoprotein: delineation of the mineral-binding and cell adhesion domains and structural analysis of the RGD domain. J Bone Miner Res, 1997, 12(8): 1210 ~ 1222
  • 5[4]Wuttke M, Muller S, Nitsche D P, Paulsson M, Hanisch F G, Maurer P. Structural characterization of human recombinant and bone-derived bone sialoprotein: Functional implications for cell attachment and hydroxyapatite binding. J Biol Chem, 2001, 276(39): 36839 ~ 36848
  • 6[5]Cereghino G P, Cereghino J L, Ilgen C, Cregg J M. Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris.Curr Opin Biotechnol, 2002, 13(4): 329 ~ 332
  • 7Bellahcene A, Menard S, Bufalino R, et al. Expression of bone sialoprotein in primary human breast cancer is associated with poor survival[J]. Int J Cancer, 1996,69(4):350-353.
  • 8Ibrahim T, Leong I, Sanchez-Sweatman O, et al. Expression of bone sialoprotein and osteopontin in breast cancer bone metastases[J]. Clin Experi Metastasis, 2000,18(3): 253-260.
  • 9Diel IJ, Solomayer EF, Selbel M J, et al. Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis[J]. Clin Cancer Res, 1999,5(12): 3914-3919.
  • 10Stubbs Ⅲ JT, Mintz KP, Eanes ED, et al. Characterization of native and recombinant bone sialoprotein delineation of the mineral-binding and cell adhesion domains and structural analysis of the RGD domain[J]. J Bone Miner Res, 1997,12(8): 1210-1222.

共引文献23

同被引文献117

引证文献4

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部